23 insiders reported 175 Form 4 transactions for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) over the past 18 months (most recent 2026-08-19). Recent activity: Lippman Evan (EVP, Business Development) Sell 18,600 shares, Zaks Tal Zvi (Director) Sell 17 shares, Hughes Eric A (See Remarks) Sell 25,578 shares, Jover Placid (See Remarks) Buy 12,827 shares, Hughes Eric A (See Remarks) Buy 52,744 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | Lippman Evan | EVP, Business Development | Sell | 18,600 | $680,291 |
| 2026-08-10 | Zaks Tal Zvi | Director | Sell | 17 | $593 |
| 2026-08-05 | Hughes Eric A | See Remarks | Sell | 25,578 | $892,051 |
| 2026-08-05 | Jover Placid | See Remarks | Buy | 12,827 | $0 |
| 2026-08-05 | Hughes Eric A | See Remarks | Buy | 52,744 | $0 |
| 2026-08-05 | Jover Placid | See Remarks | Sell | 12,827 | $447,351 |
| 2026-06-22 | Shields Matthew | EVP, Global Operations | Sell | 9,989 | $321,547 |
| 2026-06-16 | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sell | 106,563 | $3.6M |
| 2026-06-08 | BARER SOL J | Director | Buy | 21,739 | $0 |
| 2026-06-08 | LIEBERMAN GERALD M | Director | Buy | 14,492 | $0 |
| 2026-06-08 | MIGNONE ROBERTO | Director | Buy | 14,492 | $0 |
| 2026-06-08 | Crane Rosemary A | Director | Buy | 14,492 | $0 |
| 2026-06-08 | Nisen Perry | Director | Buy | 14,492 | $0 |
| 2026-06-08 | Zaks Tal Zvi | Director | Buy | 14,492 | $0 |
| 2026-06-08 | Elstein Amir | Director | Buy | 14,492 | $0 |
| 2026-06-08 | Satchi-Fainaro Ronit | Director | Buy | 14,492 | $0 |
| 2026-06-08 | Lichtenstein Chen | Director | Buy | 14,492 | $0 |
| 2026-06-08 | Francis Richard D | President and CEO | Sell | 6,153 | $211,356 |
| 2026-06-08 | Francis Richard D | President and CEO | Buy | 13,043 | $0 |
| 2026-06-04 | Shields Matthew | EVP, Global Operations | Buy | 16,195 | $0 |
| 2026-06-04 | Shields Matthew | EVP, Global Operations | Sell | 16,195 | $532,330 |
| 2026-05-18 | Lippman Evan | EVP, Business Development | Buy | 74,008 | $0 |
| 2026-05-18 | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sell | 153,251 | $5.5M |
| 2026-05-18 | Lippman Evan | EVP, Business Development | Buy | 11,841 | $0 |
| 2026-05-18 | Lippman Evan | EVP, Business Development | Sell | 5,746 | $204,467 |
Source: SEC Form 4 filings · as of 2026-08-19